Optimization of photoactive protein Z for fast and efficient site-specific conjugation of native IgG.
James Z Hui, Andrew Tsourkas
Index: Bioconjug. Chem. 25(9) , 1709-19, (2014)
Full Text: HTML
Abstract
Antibody conjugates have been used in a variety of applications from immunoassays to drug conjugates. However, it is becoming increasingly clear that in order to maximize an antibody's antigen binding ability and to produce homogeneous antibody-conjugates, the conjugated molecule should be attached onto IgG site-specifically. We previously developed a facile method for the site-specific modification of full length, native IgGs by engineering a recombinant Protein Z that forms a covalent link to the Fc domain of IgG upon exposure to long wavelength UV light. To further improve the efficiency of Protein Z production and IgG conjugation, we constructed a panel of 13 different Protein Z variants with the UV-active amino acid benzoylphenylalanine (BPA) in different locations. By using this panel of Protein Z to cross-link a range of IgGs from different hosts, including human, mouse, and rat, we discovered two previously unknown Protein Z variants, L17BPA and K35BPA, that are capable of cross-linking many commonly used IgG isotypes with efficiencies ranging from 60% to 95% after only 1 h of UV exposure. When compared to existing site-specific methods, which often require cloning or enzymatic reactions, the Protein Z-based method described here, utilizing the L17BPA, K35BPA, and the previously described Q32BPA variants, represents a vastly more accessible and efficient approach that is compatible with nearly all native IgGs, thus making site-specific conjugation more accessible to the general research community.
Related Compounds
Related Articles:
Assembly and structure of Lys33-linked polyubiquitin reveals distinct conformations.
2015-04-15
[Biochem. J. 467(2) , 345-52, (2015)]
Effect of (2)H and (18)O water isotopes in kinesin-1 gliding assay.
2014-01-01
[PeerJ 2 , e284, (2014)]
2014-07-07
[Mol. Pharm. 11(7) , 1991-6, (2014)]
Long-chain fatty acid analogues suppress breast tumorigenesis and progression.
2014-12-01
[Cancer Res. 74(23) , 6991-7002, (2014)]
2014-01-01
[Int. Arch. Allergy Immunol. 165(2) , 83-90, (2014)]